CardioHub - CardioAbstracts - HF + Kidney Link

CardioHub: CardioAbrstracts Overview

HFSA’s Cardio Abstracts program delivers expert-led discussions on recently presented clinical trial data in a convenient, interactive format. This 45-minute live seminar features Q&A with leading clinicians, recordings, and downloadable resources available for on-demand learning. This program is designed to support diverse learning styles and provide practical insights for clinicians specializing in heart failure care.

Videos in the Heart Failure and Kidney Link

Chronic kidney disease (CKD) impacts nearly 50% of individuals with heart failure, characterized by mildly reduced ejection fraction (HFmrEF) or heart failure with preserved ejection fraction (HFpEF). Patients with these conditions also often have other disorders, such as atrial fibrillation or type 2 diabetes mellitus, which can result in worse health outcomes than any of these conditions would produce individually. Join HFSA faculty as they review and answer questions about the recently presented clinical trial data and how HF and CKD may impact patient care. Watch Now!

Featured Abstracts

Lifetime Benefits of Comprehensive Medical Therapy in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial

Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial

Supporter(s)

This program was supported by an Independent Medical Education Grant from Bayer.

Summary

Cost:

FREE

Credit:

No Credit Offered

Create Account